Mingjian Lu
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Polymers and Plastics top 10%
- Polymer crystallization and properties
- Polymer Nanocomposites and Properties
Papers in
-
- Lung Cancer Diagnosis and Treatment 6
- Medical Imaging and Pathology Studies 4
- Hepatology 11
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Co-authors
- H. Keskkula (5 shared papers)Donald R. Paul (4 shared papers)Fei Gao (6 shared papers)Fujun Zhang (10 shared papers)Jiaping Li (13 shared papers)Wenzhe Fan (11 shared papers)Zhenyin Liu (8 shared papers)D. R. Paul (1 shared paper)
- Journals
- Polymer (3 papers)International Journal of Hyperthermia (3 papers)Recent Patents on Anti-Cancer Drug Discovery (2 papers)AIDS (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesPuerto Rico
In The Last Decade
Mingjian Lu
54 papers receiving 829 citations
Peers
Comparison fields: 5 of 106
- Hepatology 133
- Polymers and Plastics 174
- Virology 59
- Infectious Diseases 144
- Pulmonary and Respiratory Medicine 213
Countries citing papers authored by Mingjian Lu
This map shows the geographic impact of Mingjian Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjian Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjian Lu more than expected).
Fields of papers citing papers by Mingjian Lu
This network shows the impact of papers produced by Mingjian Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjian Lu. The network helps show where Mingjian Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingjian Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 95 | |
| 2 | 1994 | 53 | |
| 3 | 2014 | 47 | |
| 4 | 2018 | 44 | |
| 5 | 2005 | 40 | |
| 6 | 1993 | 38 | |
| 7 | 2014 | 37 | |
| 8 | 2014 | 37 | |
| 9 | 1995 | 36 | |
| 10 | 1996 | 36 | |
| 11 | 2017 | 30 | |
| 12 | 2009 | 24 | |
| 13 | 2015 | 22 | |
| 14 | 1996 | 19 | |
| 15 | 2014 | 18 | |
| 16 | 2008 | 17 | |
| 17 | 2015 | 16 | |
| 18 | 2017 | 16 | |
| 19 | 2009 | 16 | |
| 20 | 2018 | 16 |
About Mingjian Lu
Mingjian Lu is a scholar working on Pulmonary and Respiratory Medicine, Hepatology, Oncology, Surgery and Molecular Biology, having authored 62 papers that have together received 850 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Lung Cancer Diagnosis and Treatment (6 papers), Polymer crystallization and properties (6 papers), Polymer Nanocomposites and Properties (5 papers), Cancer Mechanisms and Therapy (5 papers), Medical Imaging and Pathology Studies (4 papers), HIV/AIDS Research and Interventions (4 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). The work is most often cited by research in Hepatology (133 citations), Polymers and Plastics (174 citations), Virology (59 citations), Infectious Diseases (144 citations) and Pulmonary and Respiratory Medicine (213 citations). Mingjian Lu has collaborated with scholars based in China, United States and Puerto Rico. Frequent co-authors include H. Keskkula, Donald R. Paul, Fei Gao, Fujun Zhang, Jiaping Li, Wenzhe Fan, Zhenyin Liu, D. R. Paul, Sheng Peng and Margaret Frederick. Their work appears in journals such as Polymer, International Journal of Hyperthermia, Recent Patents on Anti-Cancer Drug Discovery, AIDS and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.